Cargando…

Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications

BACKGROUND—: The incidence and clinical significance of persistent T2 hyperintensity after acute ST-segment–elevation myocardial infarction (STEMI) is uncertain. METHODS AND RESULTS—: Patients who sustained an acute STEMI were enrolled in a cohort study (BHF MR-MI: NCT02072850). Two hundred eighty-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Carberry, Jaclyn, Carrick, David, Haig, Caroline, Ahmed, Nadeem, Mordi, Ify, McEntegart, Margaret, Petrie, Mark C., Eteiba, Hany, Hood, Stuart, Watkins, Stuart, Lindsay, Mitchell, Davie, Andrew, Mahrous, Ahmed, Ford, Ian, Sattar, Naveed, Welsh, Paul, Radjenovic, Aleksandra, Oldroyd, Keith G., Berry, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753833/
https://www.ncbi.nlm.nih.gov/pubmed/29242240
http://dx.doi.org/10.1161/CIRCIMAGING.117.006586
_version_ 1783290329475055616
author Carberry, Jaclyn
Carrick, David
Haig, Caroline
Ahmed, Nadeem
Mordi, Ify
McEntegart, Margaret
Petrie, Mark C.
Eteiba, Hany
Hood, Stuart
Watkins, Stuart
Lindsay, Mitchell
Davie, Andrew
Mahrous, Ahmed
Ford, Ian
Sattar, Naveed
Welsh, Paul
Radjenovic, Aleksandra
Oldroyd, Keith G.
Berry, Colin
author_facet Carberry, Jaclyn
Carrick, David
Haig, Caroline
Ahmed, Nadeem
Mordi, Ify
McEntegart, Margaret
Petrie, Mark C.
Eteiba, Hany
Hood, Stuart
Watkins, Stuart
Lindsay, Mitchell
Davie, Andrew
Mahrous, Ahmed
Ford, Ian
Sattar, Naveed
Welsh, Paul
Radjenovic, Aleksandra
Oldroyd, Keith G.
Berry, Colin
author_sort Carberry, Jaclyn
collection PubMed
description BACKGROUND—: The incidence and clinical significance of persistent T2 hyperintensity after acute ST-segment–elevation myocardial infarction (STEMI) is uncertain. METHODS AND RESULTS—: Patients who sustained an acute STEMI were enrolled in a cohort study (BHF MR-MI: NCT02072850). Two hundred eighty-three STEMI patients (mean age, 59±12 years; 75% male) had cardiac magnetic resonance with T2 mapping performed at 2 days and 6 months post-STEMI. Persisting T2 hyperintensity was defined as infarct T2 >2 SDs from remote T2 at 6 months. Infarct zone T2 was higher than remote zone T2 at 2 days (66.3±6.1 versus 49.7±2.1 ms; P<0.001) and 6 months (56.8±4.5 versus 49.7±2.3 ms; P<0.001). Remote zone T2 did not change over time (mean change, 0.0±2.7 ms; P=0.837), whereas infarct zone T2 decreased (−9.5±6.4 ms; P<0.001). At 6 months, T2 hyperintensity persisted in 189 (67%) patients, who were more likely to have Thrombus in Myocardial Infarction flow 0 or 1 in the culprit artery (P=0.020), incomplete ST-segment resolution (P=0.037), and higher troponin (P=0.024). Persistent T2 hyperintensity was associated with NT-proBNP (N-terminal pro-B-type natriuretic peptide) concentration (0.57 on a log scale [0.42–0.72]; P=0.004) and the likelihood of adverse left ventricular remodeling (>20% change in left ventricular end-diastolic volume; 21.91 [2.75–174.29]; P=0.004). Persistent T2 hyperintensity was associated with all-cause death and heart failure, but the result was not significant (P=0.051). ΔT2 was associated with all-cause death and heart failure (P=0.004) and major adverse cardiac events (P=0.013). CONCLUSIONS—: Persistent T2 hyperintensity occurs in two thirds of STEMI patients. Persistent T2 hyperintensity was associated with the initial STEMI severity, adverse remodeling, and long-term health outcome. CLINICAL TRIAL REGISTRATION—: URL: http://www.clinicaltrials.gov. Unique identifier: NCT02072850.
format Online
Article
Text
id pubmed-5753833
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-57538332018-01-31 Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications Carberry, Jaclyn Carrick, David Haig, Caroline Ahmed, Nadeem Mordi, Ify McEntegart, Margaret Petrie, Mark C. Eteiba, Hany Hood, Stuart Watkins, Stuart Lindsay, Mitchell Davie, Andrew Mahrous, Ahmed Ford, Ian Sattar, Naveed Welsh, Paul Radjenovic, Aleksandra Oldroyd, Keith G. Berry, Colin Circ Cardiovasc Imaging Original Articles BACKGROUND—: The incidence and clinical significance of persistent T2 hyperintensity after acute ST-segment–elevation myocardial infarction (STEMI) is uncertain. METHODS AND RESULTS—: Patients who sustained an acute STEMI were enrolled in a cohort study (BHF MR-MI: NCT02072850). Two hundred eighty-three STEMI patients (mean age, 59±12 years; 75% male) had cardiac magnetic resonance with T2 mapping performed at 2 days and 6 months post-STEMI. Persisting T2 hyperintensity was defined as infarct T2 >2 SDs from remote T2 at 6 months. Infarct zone T2 was higher than remote zone T2 at 2 days (66.3±6.1 versus 49.7±2.1 ms; P<0.001) and 6 months (56.8±4.5 versus 49.7±2.3 ms; P<0.001). Remote zone T2 did not change over time (mean change, 0.0±2.7 ms; P=0.837), whereas infarct zone T2 decreased (−9.5±6.4 ms; P<0.001). At 6 months, T2 hyperintensity persisted in 189 (67%) patients, who were more likely to have Thrombus in Myocardial Infarction flow 0 or 1 in the culprit artery (P=0.020), incomplete ST-segment resolution (P=0.037), and higher troponin (P=0.024). Persistent T2 hyperintensity was associated with NT-proBNP (N-terminal pro-B-type natriuretic peptide) concentration (0.57 on a log scale [0.42–0.72]; P=0.004) and the likelihood of adverse left ventricular remodeling (>20% change in left ventricular end-diastolic volume; 21.91 [2.75–174.29]; P=0.004). Persistent T2 hyperintensity was associated with all-cause death and heart failure, but the result was not significant (P=0.051). ΔT2 was associated with all-cause death and heart failure (P=0.004) and major adverse cardiac events (P=0.013). CONCLUSIONS—: Persistent T2 hyperintensity occurs in two thirds of STEMI patients. Persistent T2 hyperintensity was associated with the initial STEMI severity, adverse remodeling, and long-term health outcome. CLINICAL TRIAL REGISTRATION—: URL: http://www.clinicaltrials.gov. Unique identifier: NCT02072850. Lippincott Williams & Wilkins 2017-12 2017-12-14 /pmc/articles/PMC5753833/ /pubmed/29242240 http://dx.doi.org/10.1161/CIRCIMAGING.117.006586 Text en © 2017 The Authors. Circulation: Cardiovascular Imaging is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
spellingShingle Original Articles
Carberry, Jaclyn
Carrick, David
Haig, Caroline
Ahmed, Nadeem
Mordi, Ify
McEntegart, Margaret
Petrie, Mark C.
Eteiba, Hany
Hood, Stuart
Watkins, Stuart
Lindsay, Mitchell
Davie, Andrew
Mahrous, Ahmed
Ford, Ian
Sattar, Naveed
Welsh, Paul
Radjenovic, Aleksandra
Oldroyd, Keith G.
Berry, Colin
Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications
title Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications
title_full Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications
title_fullStr Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications
title_full_unstemmed Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications
title_short Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment–Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications
title_sort persistence of infarct zone t2 hyperintensity at 6 months after acute st-segment–elevation myocardial infarction: incidence, pathophysiology, and prognostic implications
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753833/
https://www.ncbi.nlm.nih.gov/pubmed/29242240
http://dx.doi.org/10.1161/CIRCIMAGING.117.006586
work_keys_str_mv AT carberryjaclyn persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT carrickdavid persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT haigcaroline persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT ahmednadeem persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT mordiify persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT mcentegartmargaret persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT petriemarkc persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT eteibahany persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT hoodstuart persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT watkinsstuart persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT lindsaymitchell persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT davieandrew persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT mahrousahmed persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT fordian persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT sattarnaveed persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT welshpaul persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT radjenovicaleksandra persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT oldroydkeithg persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications
AT berrycolin persistenceofinfarctzonet2hyperintensityat6monthsafteracutestsegmentelevationmyocardialinfarctionincidencepathophysiologyandprognosticimplications